Conceptus Inc

Conceptus — Q1 2011 Earnings Presentation

33 slides from Conceptus's earnings presentation, May 10, 2011

  1. Slide 1: Conceptus, Inc. Quarterly Results First Quarter of 2011

    Conceptus, Inc. Quarterly Results First Quarter of 2011 Exhibit 99.2 May 10, 2011

  2. Slide 2: Safe Harbor

    Safe Harbor Except for the historical information contained herein, the matters discussed in this presentation include forward-looking statements, the accuracy of which is subject to risks and uncertainties. These forward- looking statements include discussions regarding: projected net sales and adj

  3. Slide 3: First Quarter of 2011 Highlights

    First Quarter of 2011 Highlights Mark Sieczkarek President and Chief Executive Officer

  4. Slide 4: Strategic Execution Impacted Growth

    Strategic Execution Impacted Growth Environmental challenges Executed recent initiatives Market growth In Q1’11, we executed several recent strategic initiatives at the expense of growing the hysteroscopic sterilization market. As anticipated, environmental challenges continued to weigh heavily on t

  5. Slide 5: High Unemployment Remains

    High Unemployment Remains High unemployment and protracted economic conditions continue to hamper consumer discretionary spending; non- urgent medical procedures such as Essure represent a lagging economic indicator U.S. employment rates by quarter 2008-2011

  6. Slide 6: COBRA Subsidies Decrease

    COBRA Subsidies Decrease 2% of households have lost COBRA subsidies recently; about half of those roll-offs are estimated to have occurred in Q1’11 Source: Department of Treasury, BLS, GE Capital Estimates Estimated U.S. households that lost COBRA subsidies by quarter, cumulative In thousands

  7. Slide 7: Employers Shift Costs to Employees

    Employers Shift Costs to Employees Average monthly worker contribution to premiums Source: Kaiser/HRET Survey of Employer-Sponsored Health Benefits, 2006–2010. Average annual health insurance premiums and worker contributions for family coverage $6,438 $13,770 114% Premium increase 147% Worker contr

  8. Slide 8: Cumulative Effect of Macro Trends…

    Cumulative Effect of Macro Trends… 9% unemployment + 13% enrolled in high deductible plans and higher employee costs due to cost shifting = 22% of workforce faces financial barriers to non-urgent procedures + Seasonal re-setting of all deductibles

  9. Slide 9: …Result in Fewer Office Visits

    …Result in Fewer Office Visits Period: OB/GYN FP/GP OB/GYN and FP/GP office visits declined further in Q1’11 Source: IMS Data Patient office visits in millions 2010 vs 2009 -15% -5% Q1’11 vs Q1’09 -23% -10% Q1’11 vs Q1’10 -8% -1% % change in select periods:

  10. Slide 10: Q1’11 Highlights

    Q1’11 Highlights Positives: Defended accounts and competitive trialing activity slowed; long-term Essure agreements increased Launched promotion of GYNECARE THERMACHOICE® III (1) to U.S. physician offices Negatives: Gave short-term ground on growing the hysteroscopic sterilization market; physician

  11. Slide 11: Defend Existing Accounts

    Defend Existing Accounts In total accounts are covered by 1-3 year 90%+ Essure exclusivity agreements by the end of Q1’11 1,100 accounts have trialed to date out of 1,300 to 1,800 accounts anticipated to trial The number of accounts entering trialing and the number of competitor cases in Essure acco

  12. Slide 12: Launch Strategic Partnership

    Launch Strategic Partnership Since our launch in February >2,000 physicians have committed to trialing GYNECARE THERMACHOICE ® III in the office within the next 12 months Leverages our in-office channel strength GEA procedure = medical need for permanent birth control Essure and GYNECARE THERMACHOIC

  13. Slide 13: Physician Metrics Pipeline

    Physician Metrics Pipeline Rate of growth slowed in Q1’11 compared to previous quarters; we will re-focus on higher growth Q1’11 Q4’10 Q3’10 Q2’10 Q1’10 Current Period Activity: Physicians entering preceptorship Physicians becoming certified Physicians transitioning to in-office Physician Base: 12,8

  14. Slide 14: Strategic Marketing

    Strategic Marketing Consumer Point of Care Physician • Resident, new-user and in-office training • Clinician education • Reimbursement support • Essure candidate identification tools • Patient support and counseling through all points of Essure procedure • Consumer awareness and education via print,

  15. Slide 15: First Quarter of 2011 Financials

    First Quarter of 2011 Financials Greg Lichtwardt Executive Vice President, Operations and Chief Financial Officer

  16. Slide 16: Q1’11 Snapshot

    Q1’11 Snapshot Net Sales ($M) Gross Margin (%) Diluted GAAP EPS Operating Exp. ($M) Adj. EBITDA (1) ($M) Q1’10 Q1’11 $33.4 80.8% 80.4% $26.6 $27.7 $25.1 ($0.08) ($0.09) $2.9 (1) Adjusted earnings before interest, taxes, depreciation, amortization and stock-based compensation. See reconciliation in A

  17. Slide 17: Worldwide Sales

    Worldwide Sales $25.4 (76%) $18.9 (71%) 18.5 (63%) 11.0 (37%) 13.7 (58%) 9.9 (42%) $7.7 (29%) $8.0 (24%) Q1’11 Net Sales (in $ millions) Q1’11 Units (in thousands) : $33.4 Q1’10 Q1’11 $26.6 29.5 Q1’10 Q1’11 23.6 Domestic International

  18. Slide 18: Q1’11 Results

    Q1’11 Q1’10 Y/Y Change Q4’10 Q/Q Change Q1’11 Results Net Sales $26.6 $33.4 (20.3%) $36.6 (27.4%) Gross Profit Margin 80.4% 80.8% nm 81.9% nm Operating Expenses $25.1 $27.7 (9.6%) $23.8 5.2% Adjusted EBITDA (1) $0.1 $2.9 (97.7%) $10.1 (99.0%) Other Income / (expense) ($1.5) ($1.5) nm ($1.6) nm Tax P

  19. Slide 19: Q1’11 Adjusted EBITDA

    Q1’11 Adjusted EBITDA Adjusted EBITDA $0.1 Amortization of intangibles Stock-based compensation ($2.9) Net loss See reconciliation in appendix Interest and other income (expense) net $ millions Depreciation expense Benefit from income taxes $1.6 ($2.3) $0.8 $1.7 $1.2

  20. Slide 20: Balance Sheet

    Balance Sheet Cash & cash equivalents Investments Accounts receivable Inventories & other assets PP&E Intangibles Goodwill Deferred tax asset Total assets ASSETS 13.3 78.4 16.0 11.9 11.2 23.5 17.0 81.5 252.8 3/31/11 A/P & other accrued ST liabilities Notes payable (1) Other accrued LT liabilities To

  21. Slide 21: Guidance

    Guidance Net Sales $135M to $150M $140.7M Gross Profit Margin 82.0% to 82.5% 80.9% Operating Expenses $102M to $105M $104.3M Adjusted EBITDA * $24.7M to $34.7M $24.8M *See appendix FY’11E as of 5/10/11 FY’10 Actual

  22. Slide 22: 2011: Strategic Plan Update

    2011: Strategic Plan Update Mark Sieczkarek President and Chief Executive Officer

  23. Slide 23: Strategic Plan Goals

    Strategic Plan Goals Goals Economic Assumptions Response Navigate current economy and make Essure Standard of Care in PBC market • Current trends continue: high unemployment, increasing enrollment in high deductible and HSA insurance plans and more employer cost shifting to employees • Patient utili

  24. Slide 24: Strategic Plan Update

    Strategic Plan Update Strategy Details Status 1. Minimize impact of competition • Defend our existing accounts against competitive trialing • Expanded sales force • Continue to educate physicians on Essure’s superior efficacy • Pace of competitive trialing in Essure accounts has slowed 2. Leverage i

  25. Slide 25: Strategic Plan Update

    Strategic Plan Update Strategy Details Status 3. Drive awareness and adoption of Essure through integrated marketing • Integrate patient and physician value proposition to increase Essure utilization at point-of- service • Utilize cost effective channels such as digital, social media and viral • Pro

  26. Slide 26: Strategic Plan Update

    Strategic Plan Update Strategy Details Status 5. Washington DC focus and reimbursement issues • Include contraception in the Preventative Services for Women’s healthcare package (Institute of Medicine initiative) • Medicaid reimbursement and cost saving issues • ACOG recognition of hysteroscopic ste

  27. Slide 27: Strategic Plan Update

    Strategic Plan Update Strategy Details Status 6. Create a pipeline of women’s health products and services • Designed to accelerate adoption of Essure • Provide more diversified offerings • Ongoing review of potential high-growth synergistic opportunities • Prefer in-office setting 7. Product enhanc

  28. Slide 28: Key Take-Aways

    Key Take-Aways 1. Progress made on recent strategic initiatives: launched promotion of GYNECARE THERMACHOICE ® III to U.S. physician offices and defended against competitive trialing 2. Re-focus on growing the market; work to increase productivity, grow physician pipeline, expand Essure utilization

  29. Slide 29: Conceptus' Inc.

    Conceptus' Inc.

  30. Slide 30: Use of Non-GAAP Financial Measures

    Use of Non-GAAP Financial Measures The Company has supplemented its GAAP net loss with a non-GAAP measure of adjusted earnings before interest, taxes, depreciation, amortization and stock-based compensation (“adjusted EBITDA”). Management believes that this non-GAAP financial measure provides useful

  31. Slide 31: GAAP to Non-GAAP Reconciliation

    GAAP to Non-GAAP Reconciliation 2011 2010 Net loss, as reported (2,928) $ (2,351) $ Adjustments to net loss: Interest and other income (expense), net (a) 1,548 1,459 Provision (benefit) for income taxes (2,304) Amortization of intangibles (b) Stock-based compensation (c) 1,695 1,729 Depreciation exp

  32. Slide 32: GAAP to Non-GAAP Reconciliation

    GAAP to Non-GAAP Reconciliation From To Net Income Guidance 1,550 $ 7,750 $ Adjustments to net income: Interest and other income (expense), net (a) 6,092 6,092 Provision for income taxes 4,750 Amortization of intangibles (b) 3,261 3,261 Stock-based compensation (c) 7,571 7,571 Depreciation expense (

  33. Slide 33: Conceptus, Inc. Revolutionizing women’s healthcare with innovative solutions

    Conceptus, Inc. Revolutionizing women’s healthcare with innovative solutions NASDAQ: CPTS CC-2773 10MAY11F

Conceptus — Q1 2011 Earnings Presentation on 6ix